Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-911.52% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SCNX · Jun 30, 2026
Scienture Holdings, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001493152-26-037754General Corporate
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
59.10% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
97.71% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-785.63% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
339.49% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
30.11% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History15 statesHistory building
Jun 30, 20220/4 normalizedLevel 3Sep 30, 20220/5 normalizedLevel 3Dec 31, 20220/4 normalizedLevel 3Mar 31, 20230/5 normalizedLevel 3Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/6 normalizedLevel 3Dec 31, 20230/5 normalizedLevel 3Jun 30, 20240/5 normalizedLevel 3Sep 30, 20243/6 normalizedLevel 3Dec 31, 20243/7 normalizedLevel 3Mar 31, 20253/5 normalizedLevel 3Sep 30, 20254/7 normalizedLevel 3Dec 31, 20255/7 normalizedLevel 3Mar 31, 20265/7 normalizedLevel 3Jun 30, 20264/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- -5182.88%
- Current
- -911.52%
- Delta
- 4271.36%
- Previous
- 374.49%
- Current
- 59.10%
- Delta
- -315.40%
- Previous
- 95.61%
- Current
- 97.71%
- Delta
- 2.11%
- Previous
- -6230.80%
- Current
- -785.63%
- Delta
- 5445.17%
- Previous
- 1409.65%
- Current
- 339.49%
- Delta
- -1070.16%
- Previous
- 181.66%
- Current
- 30.11%
- Delta
- -151.55%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Scienture Holdings, Inc. →Transitioned To · SCNX MARGIN_INCREASED →Transitioned To · SCNX PROFITABILITY_INCREASED →Transitioned To · SCNX R_AND_D_INTENSITY_DECREASED →Transitioned To · SCNX SBC_INTENSITY_DECREASED →Transitioned To · SCNX Fundamental State →Transitioned To · SCNX CASH_GENERATION_INCREASED →Transitioned To · SCNX INVENTORY_PRESSURE_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.